Patents by Inventor Steve Labbe

Steve Labbe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fusion proteins and combination vaccines comprising Protein E and Pilin A
    Patent number: 11198707
    Abstract: There is provided a method of treating chronic hepatitis B infection (CHB) in a human, comprising the steps of: a) administering to the human a composition comprising a replication-defective chimpanzee adenoviral (ChAd) vector comprising a polynucleotide encoding a hepatitis B surface antigen (HBs) and a nucleic acid encoding a hepatitis B virus core antigen (HBc); b) administering to the human a composition comprising a Modified Vaccinia Virus Ankara (MVA) vector comprising a polynucleotide encoding a hepatitis B surface antigen (HBs) and a nucleic acid encoding a hepatitis B virus core antigen (HBc); and c) administering to the human a composition comprising a recombinant hepatitis B surface antigen (HBs), recombinant hepatitis B virus core antigen (HBc) and an adjuvant.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: December 14, 2021
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A
    Publication number: 20200331972
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 22, 2020
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • Fusion proteins and combination vaccines comprising haemophilus influenzae Protein E and Pilin A
    Patent number: 10730917
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: August 4, 2020
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • Fusion proteins and combination vaccines comprising protein E and pilin A
    Patent number: 10214569
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: February 26, 2019
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A
    Publication number: 20180222946
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Application
    Filed: January 4, 2018
    Publication date: August 9, 2018
    Inventors: Normand BLAIS, Steve LABBE, Jan POOLMAN
  • Fusion proteins and combination vaccines comprising Protein E and Pilin A
    Patent number: 10023616
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: July 17, 2018
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • VACCINE
    Publication number: 20170290905
    Abstract: The present invention relates to Human Rhinovirus (HRV) Virus-Like Particles (VLPs) and methods of making HRV VLPs.
    Type: Application
    Filed: September 17, 2015
    Publication date: October 12, 2017
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Cindy CASTADO, Steve LABBE, Patrick RHEAULT
  • FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A
    Publication number: 20170029472
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Application
    Filed: June 30, 2016
    Publication date: February 2, 2017
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Normand BLAIS, Steve LABBE, Jan POOLMAN
  • FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A
    Publication number: 20160250313
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Application
    Filed: February 18, 2016
    Publication date: September 1, 2016
    Inventors: Normand BLAIS, Steve LABBE, Jan POOLMAN
  • Fusion proteins and combination vaccines comprising Protein E and Pilin A
    Patent number: 9409957
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: August 9, 2016
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • Treatment of streptococcal infections
    Patent number: 9314518
    Abstract: Methods of treating a Streptococcus pneumoniae infection are described herein.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: April 19, 2016
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe Denoel, Philippe Vincent Hermand, Steve Labbe, Jan Poolman, Stephane Rioux
  • Fusion proteins and combination vaccines comprising Protein E and Pilin A
    Patent number: 9296794
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: March 29, 2016
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A
    Publication number: 20150175670
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Application
    Filed: December 16, 2014
    Publication date: June 25, 2015
    Inventors: Normand BLAIS, Steve LABBE, Jan POOLMAN
  • FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A
    Publication number: 20150166613
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Application
    Filed: December 16, 2014
    Publication date: June 18, 2015
    Inventors: Normand BLAIS, Steve LABBE, Jan POOLMAN
  • Fusion proteins and combination vaccines comprising Protein E and Pilin A
    Patent number: 8945577
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Grant
    Filed: April 12, 2012
    Date of Patent: February 3, 2015
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • TREATMENT OF STREPTOCOCCAL INFECTIONS
    Publication number: 20140205634
    Abstract: Methods of treating a Streptococcus pneumoniae infection are described herein.
    Type: Application
    Filed: February 10, 2014
    Publication date: July 24, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe DENOEL, Philippe Vincent HERMAND, Steve LABBE, Jan POOLMAN, Stephane RIOUX
  • FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A
    Publication number: 20140056934
    Abstract: The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
    Type: Application
    Filed: April 12, 2012
    Publication date: February 27, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Normand Blais, Steve Labbe, Jan Poolman
  • TREATMENT OF STREPTOCOCCAL INFECTIONS
    Publication number: 20120328659
    Abstract: Immunogenic compositions and methods of treating a Streptococcus pneumoniae infection are described herein.
    Type: Application
    Filed: March 8, 2011
    Publication date: December 27, 2012
    Inventors: Philippe Denoel, Philippe Vincent Hermand, Steve Labbe, Jan Poolman, Stephane Rioux
  • antigens
    Patent number: 7262024
    Abstract: The present invention relates to polypeptides of Streptococcus pneumoniae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: August 28, 2007
    Assignee: ID Biomedical Corporation
    Inventors: Josée Hamel, Nathalie Charland, Bernard R. Brodeur, Denis Martin, Normand Blais, Catherine Ouellet, Steve Labbe
  • Streptococcus antigens
    Publication number: 20030232976
    Abstract: The present invention relates to polypeptides of Streptococcus pneumoniae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: December 20, 2002
    Publication date: December 18, 2003
    Inventors: Josee Hamel, Nathalie Charland, Bernard R. Brodeur, Denis Martin, Normand Blais, Catherine Ouellet, Steve Labbe